Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia.

Frontiers in oncology

Pfeiffer MM, Burow H, Schleicher S, Handgretinger R, Lang P.
PMID: 23641363
Front Oncol. 2013 Apr 29;3:99. doi: 10.3389/fonc.2013.00099. eCollection 2013.

Epigenetic drugs like histone deacetylase inhibitors (HDACi) and DNA-methyltransferase inhibitors (DNMTi) have been shown to be effective against a variety of tumor entities. Among different molecular anticancer activities of epigenetic active substances, up-regulation of natural killer (NK) cell ligands...

Cite
Pfeiffer MM, Burow H, Schleicher S, et al. Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. Front Oncol. 2013;3:99doi: 10.3389/fonc.2013.00099.
Pfeiffer, M. M., Burow, H., Schleicher, S., Handgretinger, R., & Lang, P. (2013). Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. Frontiers in oncology, 399. https://doi.org/10.3389/fonc.2013.00099
Pfeiffer, Matthias Manuel, et al. "Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia." Frontiers in oncology vol. 3 (2013): 99. doi: https://doi.org/10.3389/fonc.2013.00099
Pfeiffer MM, Burow H, Schleicher S, Handgretinger R, Lang P. Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. Front Oncol. 2013 Apr 29;3:99. doi: 10.3389/fonc.2013.00099. eCollection 2013. PMID: 23641363; PMCID: PMC3638146.
Copy Download .nbib Format: NLM
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.

The British journal of dermatology

Westphal D, Garzarolli M, Sergon M, Horak P, Hutter B, Becker JC, Wiegel M, Maczey E, Blum S, Grosche-Schlee S, Rütten A, Ugurel S, Stenzinger A, Glimm H, Aust D, Baretton G, Beissert S, Fröhling S, Redler S, Surowy H, Meier F.
PMID: 34185311
Br J Dermatol. 2021 Jun 29; doi: 10.1111/bjd.20604. Epub 2021 Jun 29.

BACKGROUND: Eccrine porocarcinoma (EPC) is a rare skin cancer arising from the eccrine sweat glands. Due to the lack of effective therapies, metastasis is associated with a high mortality rate.OBJECTIVES: To investigate the drivers of EPC progression.METHODS: We carried...

Cite
Westphal D, Garzarolli M, Sergon M, et al. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. Br J Dermatol. 2021;doi: 10.1111/bjd.20604.
Westphal, D., Garzarolli, M., Sergon, M., Horak, P., Hutter, B., Becker, J. C., Wiegel, M., Maczey, E., Blum, S., Grosche-Schlee, S., Rütten, A., Ugurel, S., Stenzinger, A., Glimm, H., Aust, D., Baretton, G., Beissert, S., Fröhling, S., Redler, S., Surowy, H., & Meier, F. (2021). High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. The British journal of dermatology, . https://doi.org/10.1111/bjd.20604
Westphal, D, et al. "High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20604
Westphal D, Garzarolli M, Sergon M, Horak P, Hutter B, Becker JC, Wiegel M, Maczey E, Blum S, Grosche-Schlee S, Rütten A, Ugurel S, Stenzinger A, Glimm H, Aust D, Baretton G, Beissert S, Fröhling S, Redler S, Surowy H, Meier F. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. Br J Dermatol. 2021 Jun 29; doi: 10.1111/bjd.20604. Epub 2021 Jun 29. PMID: 34185311.
Copy Download .nbib Format: NLM
Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients.

EBioMedicine

Hesse J, Siekierka-Harreis M, Steckel B, Alter C, Schallehn M, Honke N, Schnieringer ML, Wippich M, Braband R, Schneider M, Surowy H, Wieczorek D, Schrader J, Pongratz G.
PMID: 34666225
EBioMedicine. 2021 Nov;73:103616. doi: 10.1016/j.ebiom.2021.103616. Epub 2021 Oct 16.

BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that leads to a breakdown of tolerance to self-antigens resulting in inflammation and organ damage. The anti-inflammatory activity of CD73-derived adenosine is well documented, however, its role in SLE...

Cite
Hesse J, Siekierka-Harreis M, Steckel B, et al. Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. EBioMedicine. 2021;73:103616doi: 10.1016/j.ebiom.2021.103616.
Hesse, J., Siekierka-Harreis, M., Steckel, B., Alter, C., Schallehn, M., Honke, N., Schnieringer, M. L., Wippich, M., Braband, R., Schneider, M., Surowy, H., Wieczorek, D., Schrader, J., & Pongratz, G. (2021). Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. EBioMedicine, 73103616. https://doi.org/10.1016/j.ebiom.2021.103616
Hesse, Julia, et al. "Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients." EBioMedicine vol. 73 (2021): 103616. doi: https://doi.org/10.1016/j.ebiom.2021.103616
Hesse J, Siekierka-Harreis M, Steckel B, Alter C, Schallehn M, Honke N, Schnieringer ML, Wippich M, Braband R, Schneider M, Surowy H, Wieczorek D, Schrader J, Pongratz G. Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. EBioMedicine. 2021 Nov;73:103616. doi: 10.1016/j.ebiom.2021.103616. Epub 2021 Oct 16. PMID: 34666225; PMCID: PMC8524755.
Copy Download .nbib Format: NLM
Reverse total shoulder arthroplasty (RTSA) versus open reduction and internal fixation (ORIF) for displaced three-part or four-part proximal humeral fractures: a systematic review and meta-analysis.

EFORT open reviews

Suroto H, De Vega B, Deapsari F, Prajasari T, Wibowo PA, Samijo SK.
PMID: 34760293
EFORT Open Rev. 2021 Oct 19;6(10):941-955. doi: 10.1302/2058-5241.6.210049. eCollection 2021 Oct.

Despite rapid medical technology development, various challenges exist in three- and four-part proximal humeral fracture (PHF) management. This condition has led to a notably increased use of the reverse total shoulder arthroplasty (RTSA); however, open reduction and internal fixation...

Cite
Suroto H, De Vega B, Deapsari F, et al. Reverse total shoulder arthroplasty (RTSA) versus open reduction and internal fixation (ORIF) for displaced three-part or four-part proximal humeral fractures: a systematic review and meta-analysis. EFORT Open Rev. 2021;6(10):941-955doi: 10.1302/2058-5241.6.210049.
Suroto, H., De Vega, B., Deapsari, F., Prajasari, T., Wibowo, P. A., & Samijo, S. K. (2021). Reverse total shoulder arthroplasty (RTSA) versus open reduction and internal fixation (ORIF) for displaced three-part or four-part proximal humeral fractures: a systematic review and meta-analysis. EFORT open reviews, 6(10), 941-955. https://doi.org/10.1302/2058-5241.6.210049
Suroto, Heri, et al. "Reverse total shoulder arthroplasty (RTSA) versus open reduction and internal fixation (ORIF) for displaced three-part or four-part proximal humeral fractures: a systematic review and meta-analysis." EFORT open reviews vol. 6,10 (2021): 941-955. doi: https://doi.org/10.1302/2058-5241.6.210049
Suroto H, De Vega B, Deapsari F, Prajasari T, Wibowo PA, Samijo SK. Reverse total shoulder arthroplasty (RTSA) versus open reduction and internal fixation (ORIF) for displaced three-part or four-part proximal humeral fractures: a systematic review and meta-analysis. EFORT Open Rev. 2021 Oct 19;6(10):941-955. doi: 10.1302/2058-5241.6.210049. eCollection 2021 Oct. PMID: 34760293; PMCID: PMC8559569.
Copy Download .nbib Format: NLM
A Framework for Supervision for Mindfulness-Based Teachers: a Space for Embodied Mutual Inquiry.

Mindfulness

Evans A, Crane R, Cooper L, Mardula J, Wilks J, Surawy C, Kenny M, Kuyken W.
PMID: 26000064
Mindfulness (N Y). 2015;6(3):572-581. doi: 10.1007/s12671-014-0292-4.

Over recent decades, there has been an exponential growth in mindfulness-based interventions (MBIs). To disseminate MBIs with fidelity, care needs to be taken with the training and supervision of MBI teachers. A wealth of literature exists describing the process...

Cite
Evans A, Crane R, Cooper L, et al. A Framework for Supervision for Mindfulness-Based Teachers: a Space for Embodied Mutual Inquiry. Mindfulness (N Y). 2015;6(3):572-581doi: 10.1007/s12671-014-0292-4.
Evans, A., Crane, R., Cooper, L., Mardula, J., Wilks, J., Surawy, C., Kenny, M., & Kuyken, W. (2015). A Framework for Supervision for Mindfulness-Based Teachers: a Space for Embodied Mutual Inquiry. Mindfulness, 6(3), 572-581. https://doi.org/10.1007/s12671-014-0292-4
Evans, Alison, et al. "A Framework for Supervision for Mindfulness-Based Teachers: a Space for Embodied Mutual Inquiry." Mindfulness vol. 6,3 (2015): 572-581. doi: https://doi.org/10.1007/s12671-014-0292-4
Evans A, Crane R, Cooper L, Mardula J, Wilks J, Surawy C, Kenny M, Kuyken W. A Framework for Supervision for Mindfulness-Based Teachers: a Space for Embodied Mutual Inquiry. Mindfulness (N Y). 2015;6(3):572-581. doi: 10.1007/s12671-014-0292-4. PMID: 26000064; PMCID: PMC4432015.
Copy Download .nbib Format: NLM
Early and late apoptosis protein expression (Bcl-2, BAX and p53) in traumatic brachial plexus injury.

Journal of musculoskeletal & neuronal interactions

Suroto H, Asriel A, De Vega B, Samijo SK.
PMID: 34854392
J Musculoskelet Neuronal Interact. 2021 Dec 01;21(4):528-532.

OBJECTIVES: This research aims to analyze the expression of pro-apoptotic proteins (Bax, p53) and anti-apoptotic protein (Bcl-2) in the nerve roots of the brachial plexus following traumatic brachial plexus injury (TBPI) in the early and late stage.METHODS: A total...

Cite
Suroto H, Asriel A, De Vega B, et al. Early and late apoptosis protein expression (Bcl-2, BAX and p53) in traumatic brachial plexus injury. J Musculoskelet Neuronal Interact. 2021;21(4):528-532
Suroto, H., Asriel, A., De Vega, B., & Samijo, S. K. (2021). Early and late apoptosis protein expression (Bcl-2, BAX and p53) in traumatic brachial plexus injury. Journal of musculoskeletal & neuronal interactions, 21(4), 528-532.
Suroto, Heri, et al. "Early and late apoptosis protein expression (Bcl-2, BAX and p53) in traumatic brachial plexus injury." Journal of musculoskeletal & neuronal interactions vol. 21,4 (2021): 528-532.
Suroto H, Asriel A, De Vega B, Samijo SK. Early and late apoptosis protein expression (Bcl-2, BAX and p53) in traumatic brachial plexus injury. J Musculoskelet Neuronal Interact. 2021 Dec 01;21(4):528-532. PMID: 34854392; PMCID: PMC8672401.
Copy Download .nbib Format: NLM
Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.

Cancer gene therapy

Denisova E, Westphal D, Surowy HM, Meier F, Hutter B, Reifenberger J, Rütten A, Schulz A, Sergon M, Ziemer M, Brors B, Betz RC, Redler S.
PMID: 34045664
Cancer Gene Ther. 2021 May 27; doi: 10.1038/s41417-021-00347-z. Epub 2021 May 27.

Malignant sweat gland tumours are rare, with the most common form being Eccrine porocarcinoma (EP). To investigate the mutational landscape of EP, we performed whole-exome sequencing (WES) on 14 formalin-fixed paraffin-embedded samples of matched primary EP and healthy surrounding...

Cite
Denisova E, Westphal D, Surowy HM, et al. Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies. Cancer Gene Ther. 2021;doi: 10.1038/s41417-021-00347-z.
Denisova, E., Westphal, D., Surowy, H. M., Meier, F., Hutter, B., Reifenberger, J., Rütten, A., Schulz, A., Sergon, M., Ziemer, M., Brors, B., Betz, R. C., & Redler, S. (2021). Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies. Cancer gene therapy, . https://doi.org/10.1038/s41417-021-00347-z
Denisova, Evgeniya, et al. "Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies." Cancer gene therapy vol. (2021). doi: https://doi.org/10.1038/s41417-021-00347-z
Denisova E, Westphal D, Surowy HM, Meier F, Hutter B, Reifenberger J, Rütten A, Schulz A, Sergon M, Ziemer M, Brors B, Betz RC, Redler S. Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies. Cancer Gene Ther. 2021 May 27; doi: 10.1038/s41417-021-00347-z. Epub 2021 May 27. PMID: 34045664.
Copy Download .nbib Format: NLM
Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X.

International journal of cancer

Bucksch K, Zachariae S, Ahadova A, Aretz S, Büttner R, Görgens H, Holinski-Feder E, Hüneburg R, Kloor M, von Knebel Doeberitz M, Ladigan-Badura S, Moeslein G, Morak M, Nattermann J, Nguyen HP, Perne C, Redler S, Schmetz A, Steinke-Lange V, Surowy H, Vangala DB, Weitz J, Loeffler M, Engel C.
PMID: 34469588
Int J Cancer. 2022 Jan 01;150(1):56-66. doi: 10.1002/ijc.33790. Epub 2021 Sep 14.

Lynch syndrome (LS), Lynch-like syndrome (LLS) and familial colorectal cancer type X (FCCX) are different entities of familial cancer predisposition leading to an increased risk of colorectal cancer (CRC). The aim of this prospective study was to characterise and...

Cite
Bucksch K, Zachariae S, Ahadova A, et al. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X. Int J Cancer. 2021;150(1):56-66doi: 10.1002/ijc.33790.
Bucksch, K., Zachariae, S., Ahadova, A., Aretz, S., Büttner, R., Görgens, H., Holinski-Feder, E., Hüneburg, R., Kloor, M., von Knebel Doeberitz, M., Ladigan-Badura, S., Moeslein, G., Morak, M., Nattermann, J., Nguyen, H. P., Perne, C., Redler, S., Schmetz, A., Steinke-Lange, V., Surowy, H., Vangala, D. B., Weitz, J., Loeffler, M., Engel, C. (2022). Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X. International journal of cancer, 150(1), 56-66. https://doi.org/10.1002/ijc.33790
Bucksch, Karolin, et al. "Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X." International journal of cancer vol. 150,1 (2022): 56-66. doi: https://doi.org/10.1002/ijc.33790
Bucksch K, Zachariae S, Ahadova A, Aretz S, Büttner R, Görgens H, Holinski-Feder E, Hüneburg R, Kloor M, von Knebel Doeberitz M, Ladigan-Badura S, Moeslein G, Morak M, Nattermann J, Nguyen HP, Perne C, Redler S, Schmetz A, Steinke-Lange V, Surowy H, Vangala DB, Weitz J, Loeffler M, Engel C. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X. Int J Cancer. 2022 Jan 01;150(1):56-66. doi: 10.1002/ijc.33790. Epub 2021 Sep 14. PMID: 34469588.
Copy Download .nbib Format: NLM
Traumatic Brachial Plexus Injury in Indonesia: An Experience from a Developing Country.

Journal of reconstructive microsurgery

Suroto H, Antoni I, Siyo A, Steendam TC, Prajasari T, Mulyono HB, De Vega B.
PMID: 34470060
J Reconstr Microsurg. 2021 Sep 01; doi: 10.1055/s-0041-1735507. Epub 2021 Sep 01.

BACKGROUND:  Brachial plexus injuries (BPI) cause severe physical disability and major psycho-socioeconomic burden. Although various countries have reported BPI incidence, the data from Indonesia as the fourth most populated country in the world remains unknown. We aim to assess...

Cite
Suroto H, Antoni I, Siyo A, et al. Traumatic Brachial Plexus Injury in Indonesia: An Experience from a Developing Country. J Reconstr Microsurg. 2021;doi: 10.1055/s-0041-1735507.
Suroto, H., Antoni, I., Siyo, A., Steendam, T. C., Prajasari, T., Mulyono, H. B., & De Vega, B. (2021). Traumatic Brachial Plexus Injury in Indonesia: An Experience from a Developing Country. Journal of reconstructive microsurgery, . https://doi.org/10.1055/s-0041-1735507
Suroto, Heri, et al. "Traumatic Brachial Plexus Injury in Indonesia: An Experience from a Developing Country." Journal of reconstructive microsurgery vol. (2021). doi: https://doi.org/10.1055/s-0041-1735507
Suroto H, Antoni I, Siyo A, Steendam TC, Prajasari T, Mulyono HB, De Vega B. Traumatic Brachial Plexus Injury in Indonesia: An Experience from a Developing Country. J Reconstr Microsurg. 2021 Sep 01; doi: 10.1055/s-0041-1735507. Epub 2021 Sep 01. PMID: 34470060.
Copy Download .nbib Format: NLM
Posterior cruciate ligament research output in asian countries from 2009 - 2019: A systematic review.

Annals of medicine and surgery (2012)

Rhatomy S, Utomo DN, Suroto H, Mahyudin F.
PMID: 32994987
Ann Med Surg (Lond). 2020 Sep 12;59:76-80. doi: 10.1016/j.amsu.2020.09.006. eCollection 2020 Nov.

PURPOSE: This study aimed to determine the number of posterior cruciate ligament (PCL) publications performed in Asian countries and to identify factors associated with research output in this region.MATERIALS AND METHODS: Searches of existing academic journal articles were performed...

Cite
Rhatomy S, Utomo DN, Suroto H, et al. Posterior cruciate ligament research output in asian countries from 2009 - 2019: A systematic review. Ann Med Surg (Lond). 2020;59:76-80doi: 10.1016/j.amsu.2020.09.006.
Rhatomy, S., Utomo, D. N., Suroto, H., & Mahyudin, F. (2020). Posterior cruciate ligament research output in asian countries from 2009 - 2019: A systematic review. Annals of medicine and surgery (2012), 5976-80. https://doi.org/10.1016/j.amsu.2020.09.006
Rhatomy, Sholahuddin, et al. "Posterior cruciate ligament research output in asian countries from 2009 - 2019: A systematic review." Annals of medicine and surgery (2012) vol. 59 (2020): 76-80. doi: https://doi.org/10.1016/j.amsu.2020.09.006
Rhatomy S, Utomo DN, Suroto H, Mahyudin F. Posterior cruciate ligament research output in asian countries from 2009 - 2019: A systematic review. Ann Med Surg (Lond). 2020 Sep 12;59:76-80. doi: 10.1016/j.amsu.2020.09.006. eCollection 2020 Nov. PMID: 32994987; PMCID: PMC7501478.
Copy Download .nbib Format: NLM
Apoptosis of proximal stump postganglionic brachial plexus injury, before and after six months post-trauma.

Annals of medicine and surgery (2012)

Adyaksa G, Suroto H.
PMID: 33664944
Ann Med Surg (Lond). 2021 Feb 17;63:102156. doi: 10.1016/j.amsu.2021.02.002. eCollection 2021 Mar.

BACKGROUND: The success of the micro-surgery procedure for the treatment of postganglionic brachial plexus injury was influenced by several factors, including the surgical timing and also the viability of the proximal stump. This study evaluates the evidence of apoptosis...

Cite
Adyaksa G, Suroto H. Apoptosis of proximal stump postganglionic brachial plexus injury, before and after six months post-trauma. Ann Med Surg (Lond). 2021;63:102156doi: 10.1016/j.amsu.2021.02.002.
Adyaksa, G., & Suroto, H. (2021). Apoptosis of proximal stump postganglionic brachial plexus injury, before and after six months post-trauma. Annals of medicine and surgery (2012), 63102156. https://doi.org/10.1016/j.amsu.2021.02.002
Adyaksa, Gana, and Suroto, Heri. "Apoptosis of proximal stump postganglionic brachial plexus injury, before and after six months post-trauma." Annals of medicine and surgery (2012) vol. 63 (2021): 102156. doi: https://doi.org/10.1016/j.amsu.2021.02.002
Adyaksa G, Suroto H. Apoptosis of proximal stump postganglionic brachial plexus injury, before and after six months post-trauma. Ann Med Surg (Lond). 2021 Feb 17;63:102156. doi: 10.1016/j.amsu.2021.02.002. eCollection 2021 Mar. PMID: 33664944; PMCID: PMC7907218.
Copy Download .nbib Format: NLM
Lengthening of Massive Intercalary Cortical Allograft After Successful Graft Incorporation in Skeletally Immature Bone with Critical-Sized Defect: A Case Report with 6-year Follow-up.

Indian journal of orthopaedics

Mahyudin F, Hernugrahanto KD, Andrianus J, Widhiyanto L, Edward M, Suroto H.
PMID: 33569115
Indian J Orthop. 2020 Mar 24;55(1):203-207. doi: 10.1007/s43465-020-00087-6. eCollection 2021 Feb.

Bone allograft serves as an alternative to overcome the limitation of autograft. Some concerns, such as graft rejection, infection, and low union rate, arise from the use of bone allograft since the graft is a non-living and foreign material....

Cite
Mahyudin F, Hernugrahanto KD, Andrianus J, et al. Lengthening of Massive Intercalary Cortical Allograft After Successful Graft Incorporation in Skeletally Immature Bone with Critical-Sized Defect: A Case Report with 6-year Follow-up. Indian J Orthop. 2020;55(1):203-207doi: 10.1007/s43465-020-00087-6.
Mahyudin, F., Hernugrahanto, K. D., Andrianus, J., Widhiyanto, L., Edward, M., & Suroto, H. (2021). Lengthening of Massive Intercalary Cortical Allograft After Successful Graft Incorporation in Skeletally Immature Bone with Critical-Sized Defect: A Case Report with 6-year Follow-up. Indian journal of orthopaedics, 55(1), 203-207. https://doi.org/10.1007/s43465-020-00087-6
Mahyudin, Ferdiansyah, et al. "Lengthening of Massive Intercalary Cortical Allograft After Successful Graft Incorporation in Skeletally Immature Bone with Critical-Sized Defect: A Case Report with 6-year Follow-up." Indian journal of orthopaedics vol. 55,1 (2021): 203-207. doi: https://doi.org/10.1007/s43465-020-00087-6
Mahyudin F, Hernugrahanto KD, Andrianus J, Widhiyanto L, Edward M, Suroto H. Lengthening of Massive Intercalary Cortical Allograft After Successful Graft Incorporation in Skeletally Immature Bone with Critical-Sized Defect: A Case Report with 6-year Follow-up. Indian J Orthop. 2020 Mar 24;55(1):203-207. doi: 10.1007/s43465-020-00087-6. eCollection 2021 Feb. PMID: 33569115; PMCID: PMC7851305.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries